SCHEMBL9984155

SCHEMBL9984155

NC(=O)C1CCCN(c2ccc(N)cc2F)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.52
PBK Q96KB5 1/20 0.47
KDM4E B2RXH2 3/20 0.46
HSD17B10 Q99714 3/20 0.46
MAPT P10636 2/20 0.46
GFER P55789 2/20 0.46
MEN1 O00255 1/20 0.46
THRB P10828 1/20 0.46
ALOX15 P16050 1/20 0.46
YWHAG P61981 1/20 0.46
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 2/20 0.45
HTT P42858 2/20 0.45
LMNA P02545 1/20 0.45
MAPK1 P28482 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
PDE3B Q13370 1/20 0.45
PDE3A Q14432 1/20 0.45
NOTUM Q6P988 1/20 0.43
FPR2 P25090 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13419316 0.86 PBK (0.46) GAAPBKKDM4EHSD17B10MAPT
SCHEMBL2558977 0.84 ALDH1A1 (0.60) GAAPBKKDM4EHSD17B10MAPT
SCHEMBL9984499 0.83 MAPT (0.52) GAAKDM4EHSD17B10MAPTGFER
SCHEMBL2447262 0.82 NOTUM (0.63) PBKKDM4EMEN1ALOX15KMT2A
SCHEMBL9984703 0.82 ALDH1A1 (0.56) GAAMAPTTHRBKMT2AALDH1A1
Hydrochloric Acid SCHEMBL5425479 0.81 KDM4E (0.64) GAAPBKKDM4EHSD17B10ALDH1A1
SCHEMBL2552969 0.78 PBK (0.46) GAAPBKKDM4EHSD17B10ALDH1A1
SCHEMBL79756 0.77 WDR91 (0.52) GAAPBKKDM4EHSD17B10MAPT
SCHEMBL9983818 0.77 ALDH1A1 (0.46) GAAKDM4EHSD17B10MAPTGFER
SCHEMBL24195929 0.76 PRKDC (0.47) GAAPBKKDM4EHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110306606-A1 NOVEL 2,6-SUBSTITUTED-3-NITROPYRIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME DONG WHA PHARM. CO., LTD. (KR) 2011-12-15 US disclosed
EP-2394993-A2 NOVEL 2,6-SUBSTITUTED-3-NITROPYRIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME Dong Wha Pharm. Co., Ltd. (KR) 2011-12-14 EP disclosed
US-7671058-B2 N-(3,4-disubstituted phenyl) salicylamide derivatives INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2010-03-02 US disclosed
US-7671058-B2 N-(3,4-disubstituted phenyl) salicylamide derivatives INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) 2010-03-02 US disclosed
US-20080227784-A1 N-(3,4-disubstituted phenyl) salicylamide derivatives INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) 2008-09-18 US disclosed
US-20080227784-A1 N-(3,4-disubstituted phenyl) salicylamide derivatives INSTITUTE OF MEDICINAL MOLECULAR DESIGN. INC. (JP) 2008-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306606-A1 NOVEL 2,6-SUBSTITUTED-3-NITROPYRIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME NOS3, PTMS, NOS2 GAA 2768/4885PBK 4433/4885KDM4E 368/4885
US-20080227784-A1 N-(3,4-disubstituted phenyl) salicylamide derivatives STAT6, RELA, NFKB2 GAA 3412/4885PBK 3313/4885KDM4E 2289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.